Nonsteroidal anti-inflammatory drugs and the risk of hospitalization for acute renal failure

Archives of Internal Medicine

Volumn 156, Issue 21, 1996, Pages 2433-2439

  Gutthann, Susanne Pérez ^a,d   Rodríguez, Luis A García ^c   Raiford, Drusilla S ^a   Oliart, Alberto Duque ^a   Romeu, Josep Ris ^b  

^a NOVARTIS PHARMA AG   (Switzerland)

^b HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^d Ciba Geigy SA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; CANADA; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HOSPITALIZATION; HUMAN; INCIDENCE; MALE; NEPHROTOXICITY; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CASE-CONTROL STUDIES; FEMALE; HOSPITALIZATION; HUMANS; INCIDENCE; KIDNEY FAILURE, ACUTE; MALE; MIDDLE AGED; ODDS RATIO; RISK; RISK FACTORS; SASKATCHEWAN;

EID: 0029799834     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.156.21.2433     Document Type: Article

References (29)

1. Wang AYM, Lai KN. Drug-induced renal diseases. Adverse Drug Reaction Bull. 1994;168:635-638.
2. Baisac J, Henrich WL. Nephrotoxicity of nonsteroidal anti-inflammatory drugs. Miner Electrolyte Metab. 1994;20:187-192.
3. Morlans M, Laporte JR, Vidai X, Cabeza D, Stolley PD. End-stage renal disease and nonnarcotic analgesics: a case-control study. Br J Clin Pharmacol. 1990;30:717-723.
4. Sandier DP, Burr FR, Weinberg CR. Nonsteroidal anti-inflammatory drugs and the risk for chronic renal disease. Am Intern Med. 1991;155:165-172.
5. Perneger TV, Whelton PK, Klag MJ. Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal anti-inflammatory drugs. N Engl J Med. 1994;331:1675-1679.
6. Beard K, Perera DR, Jick H. Drug-induced parenchymal renal disease in outpatients. J Clin Pharmacol. 1988;28:431-435.
7. Guess HA, Strand LM, Helston N, Lydick E, Bergman U, Wolski K. Hospitalizations for renal impairment among users and nonusers of nonsteroidal anti-inflammatory drugs in Saskatchewan, Canada, 1983. In: Rainsford KD, Velo GP, eds. Side-effects of Anti-inflammatory Drugs. Lancaster, England: MTP Press Ltd; 1985:367-374.
8. Beard K, Lawson DH, MacFarlane GJ. Nonsteroidal anti-inflammatory drugs and acute renal disease: a case-control study. Pharmacoepidemiol Drug Safety. 1992;1:3-9.
9. Evans JMM, McGregor E, McMahon AD, et al. Nonsteroidal anti-inflammatory drugs and hospitalization for acute renal failure. QJM. 1995;88:551-557.
10. Jick H, Derby LE, García Rodríguez LA, Jick SS, Dean AD. NSAIDs and certain rare serious events: a cohort study. Pharmacotherapy. 1993;13:212-217.
11. Strand LM, Downey W. Health databases in Saskatchewan. In: Strom B, ed. Pharmacoepidemiology. 2nd ed. New York, NY: John Wiley & Sons Inc; 1994: 217-230.
12. Malcolm E, Downey W, Strand LM, McNutt M, West R. Saskatchewan Health's linkable databases and pharmacoepidemiology. Post Marketing Surveill. 1993; 6:175-264.
13. García Rodríguez LA, Walker AM, Pérez Gutthann S. Nonsteroidal anti-inflammatory drugs and gastrointestinal hospitalizations in Saskatchewan: a cohort study. Epidemiology. 1992;3:337-342.
14. García Rodríguez LA, Pérez Gutthann, Walker AM, Lueck L. Nonsteroidal anti-inflammatory drugs in acute liver injury. BMJ. 1992;305:865-868.
15. Pérez Gutthann S, García Rodríguez LA. The increased risk of hospitalizations for acute liver injury in a population with exposure to multiple drugs. Epidemiology. 1993;4:496-501.
16. Pérez Gutthann S, García Rodríguez LA, Raiford DS. Individual nonsteroidal anti-inflammatory drugs and hospitalizations for upper gastrointestinal bleeding and perforation in Saskatchewan Pharmacoepidemiology and Drug Safety. Epidemiology. In press.
17. International Classification of Diseases, Clinical Modification, Ninth Revision. Ann Arbor, Mich: Commission on Professional and Hospital Activities; 1980.
18. Disorders of the kidney and urinary tract: clinical abnormalities in uremia. In: Braunwald E, Isselbacher KJ, Petersdorf RG, et al, eds. Harrison's Principles of Internal Medicine. 12th ed. New York, NY: McGraw-Hill Book Co; 1991:pt 8.
19. Vigeral P, Baumelou A, Bénichou C, et al. Les insuffisances rénales d'origine médicamenteuse: résultats de réunions de consensus. Néphrologie. 1989;10: 157-161.
20. Walker AM, ed. Case-control studies: sampling the source population. In: Observation and Inference: An Introduction to the Methods of Epidemiology. Chestnut Hill, Mass: Epidemiology Resources Inc; 1991:75-80.
21. Von Korff M, Wagner EH, Saunders K. A chronic disease score from automated pharmacy data. J Clin Epidemiol. 1992;45:197-202.
22. Cassidy MJD, Kerr DNS. Renal disorders. In: Davies DM, ed. Textbook of Adverse Drug Reactions. New York, NY: Oxford University Press Inc; 1991: 305-343.
23. Kleinknecht D, Landais P, Goldfarb B. Les insuffisances rénales aiguës associées à des médicaments ou à des produits de contraste iodés. Néphrologie. 1986;7:41-46.
24. Norusus MJ. SPSS Advanced Statistics User's Guide. Chicago, III: SPSS Inc; 1990.
25. Hosmer DW, Lemeshow S. Confidence interval estimation of interaction. Epidemiology. 1992;3:452-456.
26. Murray MD, Brater DC. Renal toxicity of the nonsteroidal anti-inflammatory drugs. Annu Rev Pharmacol Toxicol. 1993;32:435-465.
27. Murray MD, Brater DC. Adverse effects of nonsteroidal drugs on renal function. Ann Intern Med. 1990;112:559-560.
28. Henrich WL. Neprotoxicity of NSAIDs. In: Scheier R, Gottschalk C, eds. Diseases of the Kidney. Boston, Mass: Little Brown & Co Inc; 1992:1201-1218.
29. Ray WA, Griffin MR. Use of Medicaid data for pharmacoepidemiology. Am J Epidemiol. 1989;129:837-849.